Cognitive Impact by Blood Circulating Anti-NMDAR1 Autoantibodies.

J Psychiatr Brain Sci

Department of Psychiatry, University of California San Diego, La Jolla, 92093, California, USA.

Published: June 2021

Antibodies persist months and years in blood. Chronic presence of low titers of blood circulating anti-NMDAR1 autoantibodies are sufficient to impair cognitive function in the integrity of the BBB in mice, suggesting potential cognitive damaging effects of low titers of blood circulating anti-NMDAR1 autoantibodies in the general human population and psychiatric patients. Investigation of anti-NMDAR1 autoantibodies against individual NMDAR1 antigenic epitopes may potentially provide risk biomarkers and therapeutic targets for development of immunotherapy as a precision medicine for psychiatric patients in the future.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8301263PMC
http://dx.doi.org/10.20900/jpbs.20210009DOI Listing

Publication Analysis

Top Keywords

anti-nmdar1 autoantibodies
16
blood circulating
12
circulating anti-nmdar1
12
low titers
8
titers blood
8
psychiatric patients
8
cognitive impact
4
blood
4
impact blood
4
anti-nmdar1
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!